vktx stock

This puts shares in the top 1% of all stocks when it comes to 12-month performance, according to IBD Digital. Shares of Viking stock are trading near a record high and remain well above their 50-day and 200-day moving averages, according to MarketSmith.com. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. As an investor, you want to buy stocks with the highest probability of success.

  • “WAL does not share a ton in terms of business model and balance sheet characteristics relative to the three failed banks,” Poonawala wrote in a Tuesday note.
  • The RBA unexpectedly raised rates by 25 basis points in its last meeting on May 2 to 3.85%, defying market expectations.
  • Revenue for the fiscal first quarter, however, came in at $37.26 billion.
  • On Monday, Treasury Secretary Janet Yellen reaffirmed that the U.S. faced the possibility of default as early as June 1, the so-called X date, if a deal isn’t reached between the White House and Congress.
  • The Motley Fool has no position in any of the stocks mentioned.

Google-parent Alphabet shares were also higher, up about 1.7%. Only two S&P 500 sectors out of 11 were trading in positive territory on Tuesday morning. “The failure of the Fed to acknowledge that monetary policy errors are the underlying cause of bank instability is very revealing,” Rep. Barr said.

Stocks Mentioned

McCarthy, however, has pushed for talks to broker a deal in which raising the debt limit would be tied to spending cuts. Dow member Home Depot pulled back by 2.15% after the retailer reported disappointing quarterly revenue and cut its full-year guidance, as consumers postponed large home improvement projects. Sriparna reports on pharmaceutical companies and healthcare in the United States. She has a master’s degree in English literature and post graduate diploma in broadcast journalism. Viking Therapeutics said it looked forward to reporting its 52-week data on biopsy results from some patients in the study in the first half of 2024.

Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. The thing with Fastenal is that Wall Street is wise to its long-term success so the stock is rarely cheap. But today the dividend yield of roughly 2.5% is toward the higher side of the historical yield range.

The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

vktx stock

It probably wouldn’t be fair to call the stock cheap, but it does seem like it is fairly priced (that’s backed up by the fact that the price-to-sales and price-to-earnings ratios are both in line with their five-year averages). High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.

Australia’s central bank still sees that more rate hikes ‘may still be required’

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company’s clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta.

Viking Therapeutics (VKTX) unveiled promising test results Tuesday for a liver disease treatment, sending top-rated VKTX stock to a record high. No content on the Webull Financial LLC website shall be considered as a recommendation or solicitation for the purchase or sale of securities, options, or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.

Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval

That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score.

vktx stock

In one indication of just how concentrated the U.S. stock market has become, the 10 largest stocks in the S&P 500 accounted for 87% of the index’s gains during the first quarter, Goldman said. After falling more than 300 points during https://business-oppurtunities.com/start-up-capital/ Tuesday’s session, the Dow closed in the red for the year for the first time since May 4. The stock benchmark also finished below its 50-day moving average — a closely watched technical indicator — for the first time since March 30.

Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss in a down market. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. We sell different types of products and services to both investment professionals and individual investors.

On Tuesday, the White House said Biden will cut his upcoming international trip short as he deals with debt ceiling negotiations. George Budwell has no position in any of the stocks mentioned. The company in March said its experimental obesity drug helped reduce weight and was safe in an early-stage study. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

The stock is down nearly 10% in the last five trading sessions, and has lost 53% from the start of the year. CNBC reported on Monday that Warren Buffet’s Berkshire Hathaway took a new position in the company worth upwards of $950 million. This was because April data showed “the labor market remained tight and that inflationary pressures were significant,” the board said. The company earned $3.82 per share, beating a Refinitiv forecast of $3.80 per share. Revenue for the fiscal first quarter, however, came in at $37.26 billion.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. Compare
VKTX’s historical performance
against its industry peers and the overall market. Our Quantitative Research team models direct competitors or comparable companies
from a bottom-up perspective to find companies describing their business in a
similar fashion. The stock recently fell around 25% for reasons that had nothing to do with its lead program.

Trades in your Webull Advisors account are executed by Webull Financial LLC, a member of the Securities Investor Protection Corporation (SIPC). That means your assets are protected up to $500,000 in value, including $250,000 in any cash awaiting reinvestment. Our clearing firm Apex Clearing Corp has purchased an additional insurance policy. The coverage limits provide protection for securities and cash up to an aggregate of $150 million, subject to maximum limits of $37.5 million for any one customer’s securities and $900,000 for any one customer’s cash.

“The TOPIX has broken out, and it’s broad, with roughly 80% of issues above the 200-day (compared to just 50% for S&P).” Japan’s Topix reached its highest level since August 1990, with the stock exchange closing at 2,127.18 on Tuesday. The firm’s bear case for the stock anticipates a drop to a valuation of $1. However, in his bull case, shares could pop to $60, a jaw-dropping jump of more than 400% from the previous session’s close. Stocks declined Tuesday, with the Dow Jones Industrial Average closing below its 50-day average for the first time since March 30.

Analyst Ratings

Semiconductor stocks jumped, with shares of Advanced Micro Devices rising 4.5%, and Lam Research up by 1.3%. Information technology and communication services stocks outperformed in the broader index, up about 0.35% and 0.32%, respectively. Energy and utilities stocks were the biggest laggards in the S&P 500 on Tuesday, with each sector down 2.5% and 1.9%, respectively. Cleveland Federal Reserve President Loretta Mester said Tuesday that inflation is too high for the central bank to change directions on policy now. To see more stocks making midday moves, read the full story here.

The pan-European Euro Stoxx 600 index was down by 0.3% in early deals Tuesday. On the bright side, most investors see the economic damage as limited, with 63% in the “soft landing” camp. About one-third of respondents said they think the Federal Reserve still could raise interest rates higher. The Dow Jones Industrial Average traded 127 points lower, or 0.4%.

The numbers are not adjusted for inflation, so the monthly gain, combined with the 0.4% increase in the consumer price index, showed that spending just kept up with inflation pace. The conglomerate added $126 million to its Occidental stake on Thursday, Friday and Monday at an average price of $58.06 per share, the filing showed. “Looking ahead, our sense is that the key driver of valuations will transition away from real rates and toward the growth outlook — which is typical heading into a recession!” Chris Senyek wrote in a Tuesday note. Western Alliance shares have lost more than 58% over the past three months. BMO Capital Markets upgraded Gilead Sciences shares to outperform from market perform in a Tuesday client note. The Federal Reserve’s aggressive interest rate hiking campaign helped cause the troubles in the mid-size regional banking industry, Rep. Andy Barr charged Tuesday.

Why Viking Therapeutics Stock Bolted Higher Today – The Motley Fool

Why Viking Therapeutics Stock Bolted Higher Today.

Posted: Tue, 16 May 2023 19:52:05 GMT [source]

“It is very conceivable that we’d see a number of financial markets break – with worldwide panic triggering margin calls, runs and fire sales.” Investors are anxiously awaiting progress on debt ceiling negotiations. On Monday, Treasury Secretary Janet Yellen reaffirmed that the U.S. faced the possibility of default as early as June 1, the so-called X date, if a deal isn’t reached between the White House and Congress. On Tuesday, she doubled down on her warning to raise the limit immediately. The market capitalization of Apple Inc. has surpassed that of the entire Russell 2000 for two weeks, the longest stretch on record, according to Bloomberg data.

Current valuation estimates for this untapped drug market range from $30 billion to $50 billion per year. Thus, VK2809 could easily exceed $1 billion a year in sales as an FDA-approved NASH treatment. That’s a sizable commercial opportunity for a company with a market cap of less than $2.5 billion at the time of this writing. The company is working on a treatment for nonalcoholic steatohepatitis, or NASH. With NASH, patients experience inflammation and damage in the liver unrelated to alcohol consumption.

Leave a Reply

Your email address will not be published. Required fields are marked *